Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.
Purity:
>95%
CAS Number:
[2231029-82-4]
Target:
PD-1/PD-L1|||STAT|||Akt|||COX
T76717
T76717
* VAT and and shipping costs not included. Errors and price changes excepted
